Insiders · CRL

CRL insider transactions

Charles River Laboratories International Inc. (CRL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CRL

• 4d
  Director Barg Steven was granted 422 shares, increasing direct ownership by 15% to 3,287 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 5d
  EVP & Chief Financial Officer Coleman Glenn was granted 6,640 shares, increasing direct ownership by 31% to 27,752 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 5d
  EVP, Chief Information Officer Mintz Mark was granted 2,534 shares and covered exercise/tax liability with 369 shares, increasing direct ownership by 29% to 9,546 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 5d
  EVP, Corp Strategy & Develop Laplume Joseph W was granted 5,257 shares and covered exercise/tax liability with 979 shares, increasing direct ownership by 16% to 31,298 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 5d
  SVP, Finance and CAO Knell Michael Gunnar was granted 1,837 shares and covered exercise/tax liability with 200 shares, increasing direct ownership by 11% to 16,152 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 5d
  Chief Executive Officer Girshick Birgit was granted 9,961 shares and covered exercise/tax liability with 1,582 shares, increasing direct ownership by 27% to 39,399 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 5d
  Director Foster James C covered exercise/tax liability with 1,596 shares, decreasing direct ownership by 0.57% to 279,957 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 5d
  EVP & Chief People Officer Creamer Victoria L was granted 5,135 shares and covered exercise/tax liability with 810 shares, increasing direct ownership by 17% to 30,051 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 5d
  CEVP, Disc & Safety Assessment Parisotto Shannon M was granted 4,361 shares and covered exercise/tax liability with 721 shares, increasing direct ownership by 47% to 11,382 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 10d
  EVP & Chief People Officer Creamer Victoria L covered exercise/tax liability with 346 shares, decreasing direct ownership by 1% to 25,726 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 10d
  CEVP, Disc & Safety Assessment Parisotto Shannon M gifted 7,169 shares, received a gift of 7,169 shares and covered exercise/tax liability with 273 shares, decreasing direct ownership by 49% to 7,742 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 10d
  EVP, Chief Information Officer Mintz Mark covered exercise/tax liability with 111 shares, decreasing direct ownership by 1% to 7,381 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 10d
  Chief Executive Officer Girshick Birgit covered exercise/tax liability with 618 shares, decreasing direct ownership by 2% to 31,020 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 10d
  SVP, Finance and CAO Knell Michael Gunnar covered exercise/tax liability with 87 shares, decreasing direct ownership by 0.60% to 14,515 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 10d
  EVP, Corp Strategy & Develop Laplume Joseph W covered exercise/tax liability with 428 shares, decreasing direct ownership by 2% to 27,020 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 24d
  Director Andrews Nancy C gifted 3,964 shares and received a gift of 3,964 shares, decreasing direct ownership by 73% to 1,438 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 26d
  Director Barg Steven was granted 1,438 shares, increasing direct ownership by 101% to 2,865 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 26d
  Director Thompson Craig B. was granted 1,438 shares, increasing direct ownership by 60% to 3,851 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 26d
  Director Graves Paul W was granted 1,438 shares, increasing direct ownership by 152% to 2,384 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 27d
  Director Ceesay Abraham was granted 1,438 shares, increasing direct ownership by 152% to 2,384 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 27d
  Director Mackay Martin was granted 2,845 shares, increasing direct ownership by 20% to 17,137 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 27d
  Director Andrews Nancy C was granted 1,438 shares, increasing direct ownership by 36% to 5,402 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 27d
  Director Llado George Sr. was granted 1,888 shares, increasing direct ownership by 39% to 6,702 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 27d
  Director Enyedy Mark J was granted 1,438 shares, increasing direct ownership by 152% to 2,384 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 27d
  Director Kemps-Polanco Reshema was granted 1,973 shares, increasing direct ownership by 76% to 4,563 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 27d
  Director Wilson Virginia M was granted 1,438 shares, increasing direct ownership by 29% to 6,349 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 27d
  Director Foster James C was granted 1,860 shares, increasing direct ownership by 0.67% to 281,553 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 34d
  EVP & Chief Financial Officer Coleman Glenn was granted 21,112 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 60d
  SEC Form 3 filed by new insider Coleman Glenn

  3 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 94d
  Corporate Executive VP & COO Girshick Birgit gifted 328 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 95d
  Chairman, President and CEO Foster James C was granted 16,796 shares, increasing direct ownership by 6% to 279,693 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 95d
  EVP, Corp Strategy & Develop Laplume Joseph W bought $4,364 worth of shares (25 units at $174.54), increasing direct ownership by 0.09% to 27,448 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 124d
  EVP, Corp Strategy & Develop Laplume Joseph W was granted 5,456 shares and covered exercise/tax liability with 1,749 shares, increasing direct ownership by 16% to 27,423 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 124d
  EVP & Chief People Officer Creamer Victoria L was granted 5,006 shares and covered exercise/tax liability with 1,296 shares, increasing direct ownership by 17% to 26,072 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 125d
  Chairman, President and CEO Foster James C covered exercise/tax liability with 14,664 shares and was granted 39,031 shares, increasing direct ownership by 11% to 253,677 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 125d
  Corporate Executive VP & COO Girshick Birgit was granted 9,500 shares and covered exercise/tax liability with 3,061 shares, increasing direct ownership by 31% to 26,913 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 125d
  CSVP, CAO, Interim CFO Knell Michael Gunnar was granted 1,668 shares and covered exercise/tax liability with 526 shares, increasing direct ownership by 8% to 14,602 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 125d
  EVP, Chief Information Officer Mintz Mark was granted 1,797 shares and covered exercise/tax liability with 655 shares, increasing direct ownership by 18% to 7,492 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 125d
  CEVP, Disc & Safety Assessment Parisotto Shannon M was granted 4,236 shares and covered exercise/tax liability with 1,067 shares, increasing direct ownership by 26% to 15,184 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 138d
  EVP, Corp Strategy & Develop Laplume Joseph W sold $65,488 worth of shares (400 units at $163.72), decreasing direct ownership by 2% to 23,716 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 212d
  CSVP, CAO, Interim CFO Knell Michael Gunnar was granted 2,926 shares, increasing direct ownership by 28% to 13,460 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 291d
  EVP, Corp Strategy & Develop Laplume Joseph W sold $126,080 worth of shares (800 units at $157.60), decreasing direct ownership by 3% to 24,116 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 303d
  EVP, Corp Strategy & Develop Laplume Joseph W sold $60,016 worth of shares (400 units at $150.04), decreasing direct ownership by 2% to 24,916 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 362d
  New insider Mintz Mark claimed ownership of 6,350 shares (SEC Form 3)

  3 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 363d
  EVP, Corp Strategy & Develop Laplume Joseph W gifted 385 shares, decreasing direct ownership by 1% to 25,316 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 368d
  Director Ceesay Abraham was granted 946 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 368d
  Director Enyedy Mark J was granted 946 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 368d
  Director Graves Paul W was granted 946 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 368d
  Director Barg Steven was granted 1,427 shares (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 369d
  Corporate Executive VP & CFO Pease Flavia was granted 7,152 shares and covered exercise/tax liability with 185 shares, increasing direct ownership by 67% to 17,297 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 369d
  CEVP, Disc & Safety Assessment Parisotto Shannon M was granted 5,603 shares and covered exercise/tax liability with 105 shares, increasing direct ownership by 73% to 12,997 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 369d
  EVP, Corp Strategy & Develop Laplume Joseph W covered exercise/tax liability with 155 shares and was granted 6,709 shares, increasing direct ownership by 34% to 25,701 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 369d
  CSVP&Chief Accounting Officer Knell Michael Gunnar was granted 2,064 shares and covered exercise/tax liability with 273 shares, increasing direct ownership by 20% to 10,534 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 369d
  Corporate Executive VP & COO Girshick Birgit was granted 12,239 shares and covered exercise/tax liability with 283 shares, increasing direct ownership by 22% to 65,944 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 369d
  EVP & Chief People Officer Creamer Victoria L was granted 6,252 shares and covered exercise/tax liability with 120 shares, increasing direct ownership by 38% to 22,362 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 369d
  Chairman, President and CEO Foster James C was granted 17,253 shares, increasing direct ownership by 9% to 210,685 units (SEC Form 4)

  4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 374d
  New insider Ceesay Abraham claimed no ownership of stock in the company (SEC Form 3)

  3 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 374d
  New insider Barg Steven claimed no ownership of stock in the company (SEC Form 3)

  3 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 374d
  New insider Enyedy Mark J claimed no ownership of stock in the company (SEC Form 3)

  3 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)
• 374d
  New insider Graves Paul W claimed no ownership of stock in the company (SEC Form 3)

  3 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Issuer)